The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

Ascension Wisconsin recently honored Racine paramedics and the Ascension All Saints Hospital Emergency Department for their ...

TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...

It is delivered as a single five-second intravenous bolus, which is faster than the standard of care Activase or alteplase, ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful thrombectomy results in improved likelihood of excellent outcome (modified ...

Tenecteplase is administered as a single, 5-second intravenous bolus, providing a faster and simpler option compared to the ...

Tenecteplase is not a new drug—it has been widely used for years in treating heart attacks. However, its potential to replace alteplase in stroke care has gained attention due to recent clinical ...

"Intra-arterial tenecteplase after successful thrombectomy ... "It could also improve the rate of large vessel occlusion stroke survivors who can return to society and live independently." ...

Clayton County was represented well on the Region 3-AAAA and 3-AAAAA all-region basketball teams following the regular season. The Jonesboro boys had four boys named all-region in 3-AAAA ...